Ruxolitinib - PDFSEARCH.IO - Document Search Engine

Ruxolitinib
Results: 17

#	Item
11	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Pharmaceutical Benefits Scheme Pharmacology Myelofibrosis International Prognostic Scoring System IPSS Clinical trial Medicine Health Ruxolitinib
12	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer representa Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Pharmaceutical Benefits Scheme Pharmacology Myelofibrosis International Prognostic Scoring System IPSS Clinical trial Medicine Health Ruxolitinib
13	Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo Add to Reading List Source URL: medicalxpress.com Language: English - Date: 2015-03-04 03:17:09 Janus kinase inhibitor Hsp90 inhibitors Janus kinase 2 Hsp90 Myelofibrosis Heat shock protein Essential thrombocytosis Medicine Biology Ruxolitinib
14	SPOTLIGHT SERIES Myelofibrosis M Y E L O F I B R O S I S FA S T FA C T S Myelo brosis (MF) is a rare bone marrow Add to Reading List Source URL: www.cancersupportcommunity.org Language: English Myeloproliferative disease Essential thrombocytosis Polycythemia vera Hematopoietic stem cell transplantation Leukemia Ruxolitinib Thrombocytosis Splenomegaly Acute panmyelosis with myelofibrosis Medicine Oncology Myelofibrosis
15	THE DRIVE TO DISCOVER. THE EXPERIENCE TO DELIVER. October 2014 www.incyte.com Add to Reading List Source URL: www.incyte.com Language: English - Date: 2014-10-13 15:47:24 Tyrosine kinases Ruxolitinib Myeloproliferative disease Myelofibrosis Essential thrombocytosis Polycythemia vera Thrombocytosis Splenomegaly Janus kinase 2 Medicine Oncology Hematopathology
16	Microsoft PowerPoint - 1-Widemann Welcome and FDA update.ppt Add to Reading List Source URL: www.reinscollaboration.org Language: English - Date: 2012-04-08 15:24:08 Bevacizumab Ruxolitinib Food and Drug Administration Pharmacology Pharmaceutical sciences Medicine
17	Incyte Corporate Fact Sheet VER[removed] Add to Reading List Source URL: www.incyte.com Language: English - Date: 2014-03-20 13:16:07 Signal transduction Hematopathology Ruxolitinib Janus kinase Thrombocytosis Myelofibrosis Essential thrombocytosis Polycythemia vera Splenomegaly Medicine Biology Tyrosine kinases